Meril Life Sciences: The Startup Journey That Changed Knee Replacement in India
India had a big problem. Knee replacement surgeries cost too much. Imported robots were too expensive for most hospitals. Most patients simply could not afford adequate care. Then Meril Life Sciences stepped in and changed everything. Today, Meril stands as one of India’s greatest MedTech success stories. So, let us trace this journey, from a small startup in Vapi, Gujarat, to a global leader in knee replacement and surgical robotics.
How Meril Life Sciences Started: The Vision Behind the Brand
Every great company begins with a real problem. For Meril Life Sciences, the problem was simple but urgent. India bought most of its medical devices from other countries. Patients paid very high prices. Hospitals could not afford the best tools. So the Bilakhia Group decided to fix the situation.
Shahid Bilakhia and Gafurbhai M. Bilakhia founded Meril Life Sciences in 2006. They set up the company in Vapi, Gujarat. Their goal was clear. Build world-class medical devices in India and deliver them to patients everywhere. This was a bold idea. At that time, India made almost no medical devices on its own. Most hospitals imported tools from the US and Europe. But the founders believed India could do better.
First, they built strong research and development labs between 2006 and 2008. They focused on two key areas, heart devices and bone implants. Then, by 2009–2010, they expanded their factory in Vapi. They also built quality systems that met global standards. This gave them a strong base to grow from.
What makes Meril’s early story special is the choice they made. Instead of making easy, low-cost products, they tackled the hardest problems in medical technology. That brave early decision to invest in R&D-led innovation set Meril apart from other Indian startups. It also shaped everything that came after.
Meril Life Sciences and the Orthopedic Implants Breakthrough
Knee replacement was not always Meril’s top focus. But over time, it became one of their biggest strengths. Therefore, the transition into orthopedics marked a significant milestone in Meril’s journey.
Meril entered orthopedics by buying Maxx Medical. A well-known US orthopedic device company. This was a clever move. Instead of starting from zero, Meril got access to global know-how, proven products, and important approvals. They then used this knowledge to build new and better products for Indian patients and conditions.
One of their best products from this time was the Opulent Knee System. For over 50 years, knee implants have used cobalt-chrome metal. Meril changed that. They used a Titanium Niobium Nitride (TiNbN) coating instead. This coating wears down 40% less than cobalt-chrome. Furthermore, the opulent knee is twice as strong as similar implants. It is also eight times harder and uses the most body-friendly surface material available.
As a result, surgeons loved it. Patients healed better. Hospitals needed fewer repeat surgeries. So Meril grew fast. Today, the company holds a 45% share of India’s orthopedic implants market. Their implant business earns about Rs 1,000 crore every year.
After mastering implants, Meril asked itself a key question. If they could build outstanding implants, why not build the robots that place them? That question led to the next big leap, robotic knee surgery.
The MISSO Robot: Meril Life Sciences’ Biggest Bet on Knee Replacement Innovation
The most exciting part of Meril’s journey is the MISSO robot. MISSO is India’s first home-built robotic surgery system for knee replacement. And it is changing how surgeries happen across the country.
Meril launched MISSO to help doctors during knee replacement in real time. At Rs 2 crore, MISSO costs 66% less than other robotic systems in India. That price gap is huge. It took Meril two full years to build MISSO. But the result was worth every moment of effort.
What Makes MISSO Different?
MISSO has several smart features. It uses an optical tracking sensor and a six-axis robotic arm. It also has strong safety systems built right in. Doctors can check joint gaps in real time. They can even change the surgical plan during the operation itself. Moreover, MISSO works without cutting guides. Surgeons can choose full or partial cuts based on what each patient needs.
Additionally, MISSO uses AI for surgery planning. Thanks to AI, pre-surgery planning time declines by 83%. This means surgeons spend less time preparing and more time focused on helping patients. They can also plan each surgery for the unique needs of each person. So outcomes improve, and risks go down.
Why Affordability Matters
India has a serious problem with knee surgery costs. About 3.2 million patients need knee replacements every year. Yet only around 550,000 surgeries happen annually. The gap is enormous. Cost is one of the primary reasons for this gap.
Osteoarthritis, the main cause of knee replacement. It has grown from 23 million to 62 million cases in the last 25 years. Still, most patients cannot pay for robotic surgery. So MISSO directly solves this pain point. Each MISSO surgery costs about Rs 25,000 in consumables. That is less than the Rs 35,000 needed in older robotic systems. As hospitals save money, they can pass those savings to patients. In fact, patients may get knee replacements 40–60% cheaper than before.
This is not just a business win. It is also a public health win. More patients in Tier II and Tier III cities can now get world-class orthopedic care. That is a real, lasting change in people’s lives.
Meril Life Sciences’ Growth Strategy: Funding, Expansion, and Global Reach
Growing a startup needs money, partners, and a clear plan. Meril Life Sciences got all three right.
In February 2022, Warburg Pincus invested US$210 million in Meril. This was a landmark deal. It indicated that global investors trusted Meril’s vision. It also gave Meril the funds to move faster and scale up. Then, in July 2025, the Abu Dhabi Investment Authority put in another $200 million. This deal valued Meril at $6.6 billion. In total, Meril has raised $410 million. That is a remarkable number for any Indian MedTech startup.
Going Global
From the very start, Meril wanted to serve the whole world, not just India. Today, Meril Life Sciences works in over 150 countries. It employed 10,000 people in 2024. Additionally, it runs full subsidiaries in the US, Germany, Turkey, Brazil, South Africa, China, and Bangladesh. These are not just sales offices. They handle local sales, regulatory work, and customer support, all on the ground.
Meril also plans to take MISSO global. Asia, Europe, and the US are all on the roadmap. On top of that, the same MISSO platform will soon support hip and spine surgeries too. So the robotic surgery story that started with knee replacement will keep growing into new areas.
Manufacturing at Scale
In October 2024, Prime Minister Narendra Modi opened Meril’s new factory in Vapi, Gujarat. This new plant makes orthopedic implants, cardiac stents, heart valves, and more. It also supports India’s Make in India mission strongly. Moreover, it helps Meril meet rising demand at home and across the globe.
Awards, Recognition, and the Meril Academy
Hard work brings results. And Meril has earned many awards along the way.
In 2015, Frost & Sullivan named Meril the Emerging Medical Technology Company of the Year. Then, in 2017, the Government of India gave Meril two top honors—India Medical Devices Company of the Year and India Medical Devices Export Company of the Year. These awards show that experts and leaders around the country trust Meril’s work.
But Meril did not stop at building products. They also built a world where surgeons can learn and grow. The Meril Academy trains doctors and healthcare workers around the world. It started small. Now it has grown into a network of 12 academies across key global cities. These academies run workshops, conferences, and science programs in orthopaedics, heart care, and endosurgery.
This approach is very clever. When surgeons learn on Meril systems, they trust Meril products more. Moreover, trust leads to wider use. And wider use leads to better patient outcomes. So the Meril Academy is not just a training place. It is also a long-term growth strategy that competitors find impossible to copy.
Here are the challenges that Meril Life Sciences overcame on its path to success.
No startup journey is simple. Meril faced real challenges along the way. But they found smart ways to beat each one.
Challenge 1: Competing with global giants. Companies like Stryker and Zimmer Biomet had a head start of many decades. Stryker launched its Mako surgical robot back in 2017. These companies had deep pockets and strong brands. However, Meril chose a different path. Instead of matching them on specs, Meril beat them on price and local support. That strategy worked very well.
Challenge 2: Getting global approvals. Selling medical devices globally needs approvals from agencies like the CDSCO in India, the CE in Europe, and the FDA in the US. Each approval takes time, money, and strong clinical proof. Yet Meril worked through this long process for many products. As a result, they now sell in over 150 countries with full regulatory backing.
Challenge 3: Getting hospitals to adopt new tech. Many hospitals were slow to accept robotic systems. They worried about high costs, long training times, and slow after-sales service. So Meril built MISSO right here in India. Because of these factors, they could offer faster service, local training, and cheaper spare parts. These practical advantages helped Meril win hospital after hospital across the country.
Each challenge, therefore, made Meril stronger and far smarter.
What’s Next for Meril Life Sciences: The Future of Affordable Surgical Robotics
The journey of Meril Life Sciences is far from complete. In fact, the best chapters may still lie ahead.
In 2025, Meril launched MIZZO Endo 4000. This is a soft-tissue robotic surgery system for minimally invasive procedures. It works across many fields—general surgery, urology, gynecology, cancer care, and more. So Meril is no longer just an orthopedic company. It is now building a full surgical robotics platform for the future.
Meril also aims to sell 100 MISSO robots in the first year. Then, they plan to reach 1,000 units within three years. Given that millions of patients still wait for knee replacement surgery, this target is very realistic. Furthermore, as more hospitals in smaller cities look to upgrade, demand will continue to rise steadily.
Most importantly, Meril is making robotic surgery available to everyone. Not just the wealthy. Robotic knee replacement should not be only for patients in big cities. By building affordable, India-made robots. And backing them with local training, Meril puts precision surgery within reach of every patient across the country. That mission is both bold and deeply meaningful.
Conclusion: Meril Life Sciences Is Rewriting the Rules of Medical Innovation
The startup journey of Meril Life Sciences is truly inspiring. What started as a bold idea by the Bilakhia Group in 2006. It has grown into a global MedTech force. Today, Meril competes with the world’s best in knee replacement and surgical robotics.
Along the way, Meril bought Maxx Medical to enter orthopedics. They then created the TiNbN-coated Opulent Knee System. Thereafter, they built MISSO at 66% lower cost than imported robots. And finally, they expanded into 150+ countries with a team of 10,000 people. Every step was driven by one clear goal: to make great healthcare affordable for everyone.
So what sets Meril apart? It is their why. Meril does not chase profits alone. They also chase impact. They want patients in small towns to get the same care as patients in big cities. Want surgeons everywhere to have the best tools. That mission makes Meril more than just a company. It gives Meril a movement.
If you are a healthcare investor, a doctor, or simply someone who loves Indian innovation, Meril’s story sends a clear message. Start with a real problem. Invest in R&D. Build for affordability. And never stop growing your vision.
Visit the Meril Life Sciences website today. Explore their knee replacement solutions and robotic surgery platforms. Join a healthcare revolution that is truly made in India.
Tabassum Shaik is an Author, Researcher, and SEO Specialist with 8+ years of experience creating informative content on business, startups, entrepreneurship, marketing, technology, and digital trends. She focuses on sharing accurate, practical, and easy-to-understand insights for readers.
